Our Customers
Products & Pipeline
Science & DTx
For business
About us
Contact us
US Payers

Stephen Freer

As our EVP of Clinical, Stephen makes sure we deliver world-class mental health treatments and products. He holds ieso to account in its mission to put patients and their outcomes at the core of everything we do.

Before joining ieso in 2016, he held senior clinical leadership roles within the public healthcare sector, and he continues to hold his accreditation as a Cognitive Behavioural Therapist. This has enabled Stephen to combine his commercial, operational, and clinical expertise to improve mental health treatment pathways. For his work increasing patient access to evidence-based mental health treatments, he has been profiled by the NHS Leadership Academy.

He is currently completing an Executive MBA, building on his PGCert in Healthcare Leadership and MSc in Psychological Therapies Research.

“ieso’s potential for large scale impact – not just here in the UK, but globally – is such an exciting prospect. The clinical data insights and quality assurance we have here means we’re constantly able to improve the treatment we offer. And the feedback loop is immediate. And exponential. Every day, as our patients get better, so do we."

The Board and Leadership Team

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Clare Hurley

Chief Operating Officer (UK)

Danah Tangen

SVP US Market Development

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Charlotte Housden

Interim Chief Product Officer

Dr Andrew Welchman

EVP Impact & Corporate Development

Siobhan Brown

HR Director

Robert Spavin

EVP Legal & IP